Methods of preparation of conjugates
US-9353127-B2 · May 31, 2016 · US
US9890179B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9890179-B2 |
| Application number | US-201615216517-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 21, 2016 |
| Priority date | Jul 21, 2015 |
| Publication date | Feb 13, 2018 |
| Grant date | Feb 13, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
Opening claim text (preview).
The invention claimed is: 1. A method of preparing a compound of formula (17a): or a salt thereof, said method comprising reacting a compound of formula (14a) with a monomer compound of formula (d 1 ), wherein X 3 is —Cl; P 3 is H or an amine protecting group; and R 101 is (C 1 -C 3 )alkyl, pyridyl, or nitropyridyl. 2. The method of claim 1 , wherein the compound of formula (14a) is reacted with a monomer of formula (d 1 ) in the presence of an alcohol activating agent and an azodicarboxylate. 3. The method of claim 2 , wherein the alcohol activating agent is triphenylphosphine. 4. The method of claim 2 , wherein the azodicarboxylate is selected from the group consisting of: diethyl azodicarboxylate (DEAD), diisopropyl azodicarboxylate (DIAD), 1,1′-(azodicarbonyl)dipiperidine (ADDP), and ditertbutyl azodicarboxylate (DTAD). 5. The method of claim 2 , wherein the compound of formula (14a) is reacted with the monomer compound of formula (d 1 ), wherein P 3 is H, to form a compound of formula (17a′): 6. The method of claim 2 , wherein P 3 is an amine protecting group and the method further comprises the step of reacting the compound of formula (17a) with an amine deprotecting reagent to form a compound of formula (17a′): 7. A method of preparing a compound of formula (18a), or a pharmaceutically acceptable salt thereof, said method comprising reacting a compound of formula of (17a): with a monomer of formula (a 1 ): wherein X 3 is —Cl; P 3 is H or an amine protecting group; and R 101 is (C 1 -C 3 )alkyl, pyridyl, or nitropyridyl. 8. The method of claim 7 , wherein the compound of formula (17a) is reacted with a monomer compound of formula (a 1 ) in the presence of a base. 9. The method of claim 8 , wherein the base is sodium carbonate, potassium carbonate, cesium carbonate, sodium hydride, or potassium hydride. 10. The method of claim 9 , wherein the base is potassium carbonate. 11. The method of claim 8 , wherein the compound of formula (17a) is reacted with a monomer compound of formula (a 1 ) in the presence of a polar aprotic solvent. 12. The method of claim 11 , wherein the polar aprotic solvent is dimethylformamide or dimethylacetamide. 13. The method of claim 8 , wherein the compound of formula (17a) is reacted with monomer of formula (a 1 ), wherein P 3 is H, to form a compound of formula (Ia′): 14. The method of claim 8 , wherein P 3 is an amine protecting group and the compound of formula (18a) is further reacted with an amine deprotecting reagent to form a compound of formula (Ia′): 15. A method of preparing a compound of formula (18a), or a pharmaceutically acceptable salt thereof, said method comprising the steps of: (1) reacting the compound of formula (14a): or a salt thereof, with a reduced monomer compound of formula (d 1 ), in the presence of an alcohol activating agent to form a compound of formula (17a): or a salt thereof; and (2) reacting the compound of formula of (17a) with a monomer of formula (a 1 ): to form a compound of formula (18a), or a pharmaceutically acceptable salt thereof, wherein X 3 is —Cl; P 1 is an alcohol protecting group; P 3 is H or an amine protecting group; and R 101 is (C 1 -C 3 )alkyl, pyridyl, or nitropyridyl. 16. The method of claim 15 , wherein the compound of formula (17a) is reacted with monomer of formula (a 1 ), wherein P 3 is H, to form a compound of formula (Ia′): 17. The method of claim 15 , wherein P 3 is an amine protecting group and the compound of formula (18a) is further reacted with an amine deprotecting reagent to form a compound of formula (Ia′): 18. The method of claim 15 , wherein the compound of formula (14a) or a salt thereof is prepared a method comprising the following steps: (1) reacting a chlorinating reagent with a compound of formula (2a), to form a compound a compound of formula (13a), or a salt thereof; (2) reacting the compound of formula (13a) with an alcohol deprotecting reagent to form the compound of formula (14a) or a salt thereof. 19. The method of claim 18 , wherein the compound of formula (2a) is prepared by reacting a compound of formula (1a) with an alcohol protecting reagent
Antineoplastic agents · CPC title
by reaction of hydroxy compounds with sulfonic acids or derivatives thereof · CPC title
Ortho-condensed systems · CPC title
and aliphatic · CPC title
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.